Michael Halank

10.1k total citations
153 papers, 5.0k citations indexed

About

Michael Halank is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Michael Halank has authored 153 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Pulmonary and Respiratory Medicine, 69 papers in Cardiology and Cardiovascular Medicine and 15 papers in Surgery. Recurrent topics in Michael Halank's work include Pulmonary Hypertension Research and Treatments (126 papers), Heart Failure Treatment and Management (26 papers) and Cardiovascular Issues in Pregnancy (26 papers). Michael Halank is often cited by papers focused on Pulmonary Hypertension Research and Treatments (126 papers), Heart Failure Treatment and Management (26 papers) and Cardiovascular Issues in Pregnancy (26 papers). Michael Halank collaborates with scholars based in Germany, Switzerland and United States. Michael Halank's co-authors include Marius M. Hoeper, Ralf Ewert, Heinrike Wilkens, Ekkehard Grünig, Christian Opitz, Gert Hoeffken, Hossein Ardeschir Ghofrani, Nicola Ehlken, Hans-Juergen Seyfarth and Roland Wensel and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Michael Halank

143 papers receiving 4.8k citations

Peers

Countries citing papers authored by Michael Halank

Since Specialization

Citations

This map shows the geographic impact of Michael Halank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Halank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Halank more than expected).

Fields of papers citing papers by Michael Halank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Halank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Halank. The network helps show where Michael Halank may publish in the future.

Co-authorship network of co-authors of Michael Halank

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Halank. A scholar is included among the top collaborators of Michael Halank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Halank. Michael Halank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study 2024 ·Circulation ·Marius M. Hoeper, (unknown), (unknown), Hanno Leuchte, Christian Opitz, Michael Halank, Hans-Juergen Seyfarth, Stephan Baldus, Johann Bauersachs, Michael Böhm, Hossein Ardeschir Ghofrani, Stavros Konstantinides, Karen M. Olsson, Rolf Wachter, Carolyn S.P. Lam, Behnaz Aminossadati, Stephan Rosenkranz	13
2	Pulmonale Hypertonie assoziiert mit Lungenerkrankungen 2023 ·Pneumologie ·Michael Halank, Katarina Zeder, Natascha Sommer, Nikolaus Kneidinger, Jürgen Behr, Silvia Ulrich, Matthias Held, Thomas Köhler, Vasile Foris, (unknown), Claus Neurohr, (unknown), S. J. Holt, Dirk Skowasch	1
3	Is iron deficiency caused by BMPR2 mutations or dysfunction in pulmonary arterial hypertension patients? 2023 ·Pulmonary Circulation ·(unknown), Ekkehard Grünig, Nicola Benjamin, Hans‐Jürgen Seyfarth, Michael Halank, Marc A. Schneider, (unknown), Daniel Kazdal, Katrin Hinderhofer, Panagiota Xanthouli, Benjamin Egenlauf, Satenik Harutyunova, Marius M. Hoeper, Danny Jonigk, Richard Sparla, Martina U. Muckenthaler, Christina A. Eichstaedt	4
4	Prognostic Relevance of Cardiopulmonary Exercise Testing for Patients with Chronic Thromboembolic Pulmonary Hypertension 2022 ·Journal of Cardiovascular Development and Disease ·Ralf Ewert, Till Ittermann, (unknown), (unknown), (unknown), (unknown), Michael Halank, Jörg Winkler, (unknown), Beate Stubbe, (unknown), Hans‐Jürgen Seyfarth, Christian Opitz, Dirk Habedank, Roland Wensel, Matthias Held	6
5	Prognostic value of cardiopulmonary exercise testing in patients with systemic sclerosis 2019 ·BMC Pulmonary Medicine ·Ralf Ewert, Till Ittermann, Dirk Habedank, Matthias Held, Tobias Lange, Michael Halank, Jörg Winkler, Sven Gläser, Horst Olschewski, Gábor Kovács	28
6	Anxiety, Depression, and Health-Related QOL in Patients Diagnosed with PAH or CTEPH 2017 ·Lung ·(unknown), (unknown), Michael Halank, Heinrike Wilkens, Philipp Kolb, B. Jany, Matthias Held	24
7	Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study 2017 ·Respiratory Medicine ·Michael Halank, Marius M. Hoeper, Hossein Ardeschir Ghofrani, F. Joachim Meyer, G. Stähler, Jürgen Behr, Ralf Ewert, (unknown), Pablo Colorado, Sylvia Nikkho, Friedrich Grimminger	29
8	Safety and efficacy of exercise training in various forms of pulmonary hypertension 2012 ·European Respiratory Journal ·Ekkehard Grünig, Mona Lichtblau, Nicola Ehlken, Hossein Ardeschir Ghofrani, Frank Reichenberger, Gerd Staehler, Michael Halank, Christine Fischer, Hans‐Jürgen Seyfarth, Hans Klose, Andreas Meyer, Stephan Sorichter, Heinrike Wilkens, Stephan Rosenkranz, Christian Opitz, Hanno Leuchte, Gabriele Karger, Rudolf Speich, Christian Nagel	161
9	Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension 2012 ·International Journal of Cardiology ·Roland Wensel, Dárrel P. Francis, F. Joachim Meyer, Christian Opitz, Leonhard Bruch, Michael Halank, Jörg Winkler, Hans‐Jürgen Seyfarth, Sven Gläser, Friedrich C. Blumberg, Anne Obst, Michael Dandel, Roland Hetzer, Ralf Ewert	88
10	Hämoptysen infolge Pulmonalvenenstenose und -verschluss nach Pulmonalvenen-Isolation bei Vorhofflimmern 2011 ·DMW - Deutsche Medizinische Wochenschrift ·S. Braun, Martin Kolditz, Michael Halank, Janelle Weise, Ivan Platzek, Philipp Sommer, (unknown)	2
11	Ambrisentan Improves Exercise Capacity and Symptoms in Patients with Portopulmonary Hypertension 2011 ·European Respiratory Journal ·Michael Halank, Lars Knudsen, Hans-Juergen Seyfarth, Ralf Ewert, (unknown), Martin Kolditz, Gert Hoeffken, Marius M. Hoeper	0
12	Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study 2010 ·European Respiratory Journal ·Hossein Ardeschir Ghofrani, Marius M. Hoeper, Michael Halank, F. J. Meyer, G. Staehler, Jürgen Behr, Ralf Ewert, Gerrit Weimann, Friedrich Grimminger	183
13	Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension 2007 ·Clinical Research in Cardiology ·Ralf Ewert, Christian Opitz, Roland Wensel, Jörg Winkler, Michael Halank, Stephan B. Felix	26
14	Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension 2006 ·Circulation ·Derliz Mereles, Nicola Ehlken, (unknown), Sedigheh Ghofrani, Marius M. Hoeper, Michael Halank, F. Joachim Meyer, Gabriele Karger, J. Buss, Jana Juenger, Nicole Holzapfel, Christian Opitz, Jörg Winkler, Felix Herth, Heinrike Wilkens, Hugo A. Katus, Horst Olschewski, Ekkehard Grünig	466
15	Portopulmonary hypertension 2006 ·Journal of Gastroenterology ·Michael Halank, Ralf Ewert, Hans-Juergen Seyfarth, Gert Hoeffken	2
16	Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension 2006 ·European Respiratory Journal ·Marius M. Hoeper, Hanno Leuchte, Michael Halank, Heinrike Wilkens, F. Joachim Meyer, Hans-Juergen Seyfarth, Roland Wensel, (unknown), H. J. Bremer, Stefan Kluge, Gert Hoeffken, Jürgen Behr	216
17	Portopulmonary hypertension 2006 ·Journal of Gastroenterology ·Michael Halank, Ralf Ewert, Hans-Juergen Seyfarth, Gert Hoeffken	21
18	Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers 2006 ·Journal of the American College of Cardiology ·Marius M. Hoeper, Stephen H. Lee, Robert Voswinckel, Massimiliano Palazzini, Xavier Jaïs, Alessandro Marinelli, Robyn J. Barst, Hossein Ardeschir Ghofrani, Zhi‐Cheng Jing, Christian Opitz, Hans-Juergen Seyfarth, Michael Halank, Vallerie V. McLaughlin, Ronald J. Oudiz, Ralf Ewert, Heinrike Wilkens, Stefan Kluge, (unknown), Eva Baroke, Lewis J. Rubin	404
19	Portopulmonale Hypertonie 2005 ·Zeitschrift für Gastroenterologie ·Michael Halank, (unknown), Martin Kolditz, Gert Hoeffken	3
20	Diffuse Proliferation der glatten Muskulatur der Lunge und schwere pulmonale Hypertonie 2005 ·Pneumologie ·Michael Halank, Ralf Ewert, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact